Celestica Balance Sheet Health
Financial Health criteria checks 5/6
Celestica has a total shareholder equity of $1.6B and total debt of $891.0M, which brings its debt-to-equity ratio to 57.2%. Its total assets and total liabilities are $5.8B and $4.3B respectively. Celestica's EBIT is $616.9M making its interest coverage ratio 34.5. It has cash and short-term investments of $307.8M.
Key information
57.2%
Debt to equity ratio
US$891.00m
Debt
| Interest coverage ratio | 34.5x |
| Cash | US$307.80m |
| Equity | US$1.56b |
| Total liabilities | US$4.28b |
| Total assets | US$5.83b |
Recent financial health updates
No updates
Recent updates
Celestica: Do Not Miss Out The Golden Pre-Earnings Opportunity
Apr 21Celestica: What's Fueling This Silent Climber
Apr 11Celestica: The AI Stock Set For High Growth After A 20% Drop
Mar 24Celestica: Overvaluation Amid Weakening AI Craze
Mar 18Celestica: A Solid Buying Opportunity
Mar 09Celestica: Fueled By Relentless Catalysts
Feb 25Celestica: Management And Analysts Upped Guidance/Estimates Still Appear Conservative
Feb 11Celestica: Room For Margin And Multiple Expansion
Feb 05Celestica Q4 Earnings: Why DeepSeek Fears Are Overblown
Jan 30Unlocking Growth Potential: Why Celestica's ODM Transition Is A Game Changer For Investors
Jan 14Celestica: A Trifecta Of Growth, Margin Expansion And Improving Cash Flow Conversion
Dec 26Celestica: The AI Datacenter's Supply Chain Winner
Dec 04Celestica: AI Capex Boom Still Promising, Baked-In Premium Triggers Downgrade
Nov 04Celestica Q3: Defying Expectations With Undemanding Valuations
Oct 24Celestica: Still A Value Buy Despite The Recent Recovery
Oct 12Celestica: Institutional Investors Are Buying, So Am I
Sep 27Celestica: Weak Bargaining Power, Hold For Now
Sep 04Celestica: Bullish Expectations May Be Priced In
Aug 19Celestica: Q2 2024, Why Do I Upgrade The Stock To 'Buy' Again
Aug 02Celestica Stock Has Only Become Cheaper -- 'Buy' Before Earnings Release
Jul 23Celestica's AI Pivot Will Continue To Fuel Its 300% Risky Rally
Jul 11Celestica: High Quant Rating Looks Well-Deserved
Jun 25Assessing Celestica's Near-Term Prospects Given Meteoric Rise
Jun 10Celestica: An AI Play With Significant Upside
May 27Celestica: Explosive Momentum And Growth At An Attractive Price (SA Quant)
May 03Celestica: Time To Load Up
Apr 22Celestica: AI Wave Caution
Mar 18Celestica: A Deep Dive Into A Mysterious Grower
Mar 11Celestica: Why I'm Buying This Stock
Feb 15Celestica: Strong Q4 Earnings, Reiterate Buy
Feb 02Celestica: Why It Remains A Long-Term Strong Buy
Jan 14Why Celestica Stock Is A Buy Into Q4 Earnings
Jan 03Why Celestica Remains Among The Top Rated Stocks Heading Into 2024
Dec 13Celestica: Still A Bargain At Current Levels
Dec 04Riding The Celestica Wave: Q3 Earnings, Buyback Plans, And Future Forecasts
Nov 16Financial Position Analysis
Short Term Liabilities: CLS's short term assets ($4.4B) exceed its short term liabilities ($3.1B).
Long Term Liabilities: CLS's short term assets ($4.4B) exceed its long term liabilities ($1.2B).
Debt to Equity History and Analysis
Debt Level: CLS's net debt to equity ratio (37.5%) is considered satisfactory.
Reducing Debt: CLS's debt to equity ratio has increased from 40.6% to 57.2% over the past 5 years.
Debt Coverage: CLS's debt is well covered by operating cash flow (55.7%).
Interest Coverage: CLS's interest payments on its debt are well covered by EBIT (34.5x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/28 04:05 |
| End of Day Share Price | 2025/04/25 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Celestica Inc. is covered by 32 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| James Kelleher | Argus Research Company |
| Ishan Majumdar | Baptista Research |
| Dong Wang | Barclays |